leisure time -WSS

leisure time

author：comprehensive 2025-08-12 09:08:48 - browse：3

Adam's take main illustration — Molly Ferguson/STAT

Happy Groundhog Day eve. Some takes and thoughts on Bluebird Bio’s quest for gene therapy profits, a reality check on Vertex’s highly touted pain drug, and more ADC investor FOMO.

Bluebird and the case for gene therapy profits

Genetic treatments that are potential cures for inherited diseases are a huge medical advance, but can these transformational (and expensive) products become a profitable business? I’m not sure anyone knows yet for sure, but pay attention to Bluebird Bio over the next year for some clues.

Bluebird is unique among the biotech and pharma companies selling gene therapies (or CRISPR-based medicines) today because it has no other marketed products. With the recent approval of Lyfgenia for sickle cell disease (cost: $3.1 million), Bluebird sells three gene therapies. The other products are Zynteglo for beta thalassemia ($2.8 million) and Skysona for cerebral adrenoleukodystrophy ($3 million). It’s a pure-play commercial gene therapy business. It’s not even trying to develop additional gene therapies currently. R&D expenses are tied to gathering long-term data on its existing products.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Leqembi, other new Alzheimer’s drugs require better biomarkers

WSS

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

NIH trials fail to test meaningful long Covid therapies, experts say

How to use technology to prevent future drug shortages

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

Study: Pain burden is higher in Black NFL players than white ones

Bulgari apologizes to China for listing Taiwan as a country after online backlash

entertainment

leisure time

Bluebird and the case for gene therapy profits

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Police still searching for prisoner who escaped from NYC hospital

Supreme Court strikes down use of affirmative action

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

United colonoscopy coverage change 'may cost lives,' doctors say

Wegovy trial has doctors encouraged over new possibilities

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Friends ask where James Watson's attitudes about race came from

explore

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

New research casts further doubt on a common procedure used with IVF

Lecanemab for Alzheimer's is coming. Is the health system ready?

Drastic changes should bring profitability, startup health insurers say

For Cytokinetics, FDA rejection of heart drug would help, not hinder

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

focus

focus

Wikipedia

Wikipedia